News in the Life Sciences Industry

WARRINGTON, Pa., Aug. 14, 2019 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today reported financial... Read more ››

PARAMUS, N.J., Aug. 14, 2019 /PRNewswire/ -- DON Recovery Services (DRS) has chosen to implement the MedicsCloud Addiction Medicine Clinical and... Read more ››

SAN DIEGO, Aug. 14, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, today reported financial results for its first quarter ended June 30, 2019 and provided an update on recent developments.

SARASOTA, Fla., Aug. 14, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company which was granted FDA clearance for its Intravaginal Culture System, INVOcell(®), today announced financial results for the second quarter of 2019, ended June 30, 2019.

BOSTON, Aug. 14, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company... Read more ››

BALTIMORE, Aug. 14, 2019 /PRNewswire/ -- Leidos (NYSE: LDOS) and the Baltimore Ravens announce today they... Read more ››

PASADENA, Calif., Aug. 14, 2019 /PRNewswire/ -- Huntington Hospital announced today that local philanthropists, Terri and Jerry Kohl have made a gift of $7 million to support the expansion of its new Huntington Heart and Vascular Center.

Adjusted EBITDA up more than $5M (CDN) versus prior quarter;
Company positioned to bring CBD products to U.S. market by end of fiscal 2020;
Record harvest of over 40,000 kg

HONOLULU, Aug. 14, 2019 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) announced today that it filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed follow-on public offering of up to $15 million of the Company's common stock and warrants. The... Read more ››

HONOLULU, Aug. 14, 2019 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) today filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019.